Whole-genome sequencing maps the genetics of albinism

A single eye movement — the involuntary, rhythmic oscillation called nystagmus — is often the first sign a clinician notices. In many children, that movement traces back to albinism. A new study published in npj Genomic Medicine set out to understand exactly which genes are responsible, and found the picture is far more varied than previously mapped.

Researchers used whole-genome sequencing to analyse a cohort of patients presenting with infantile nystagmus and albinism, according to the study. Unlike older targeted gene panels, whole-genome sequencing reads every part of the genetic code — including regions that standard tests routinely miss. The approach, the researchers reported, uncovered a broader range of genetic variants than prior methods had identified.

What the sequencing revealed

The study found diverse genetic causes underlying what clinicians often treat as a single condition, according to the authors. Different gene variants, the researchers reported, also produced distinct phenotypic signatures — meaning the specific pattern of pigmentation loss, vision impairment, and nystagmus varied depending on which gene was involved. That distinction matters clinically: two children with similar appearances may carry entirely different genetic causes, and may respond differently to care.

The findings add to a growing body of evidence that albinism is not one condition but a family of related conditions, each with its own genetic origin. Researchers identified variants across multiple known albinism-associated genes, and in some cases flagged candidate genes not previously linked to the condition, according to the published report.

Why diagnosis precision matters

For families navigating an albinism diagnosis, the gap between a clinical observation and a confirmed genetic cause can be years wide. Whole-genome sequencing, the study suggested, could shorten that gap — and in doing so, give clinicians more precise information about what a child's vision and pigmentation trajectory may look like.

The research also has implications for genetic counselling. When the specific variant is known, families can receive more accurate information about inheritance patterns and recurrence risk, according to the authors.

The study does not offer a treatment. What it offers is resolution — a clearer view of why albinism presents the way it does, at the level of individual genes. For a community that has historically contended with misdiagnosis and delayed diagnosis, that clarity is not a small thing.

The full study is available through npj Genomic Medicine, published by Nature.